<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7118644\results\search\zoonosis\results.xml">
  <result pre="development and regulatory body approved therapies. In particular, the current" exact="coronavirus disease 2019" post="(COVID-19) pandemic has quickly intensified interest in developing treatment"/>
  <result pre="November 2019, there were 2494 laboratory-confirmed cases of infection with" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) that reached 27 countries and had a"/>
  <result pre="generated intense interest in vaccine development and treatment options for" exact="coronavirus disease 2019" post="(COVID-19) [6,7]. Remdesivir (GS-5734, Fig. 1a) is an investigational"/>
  <result pre="respiratory syncytial virus, and Hendra virus), and Filoviridae (such as" exact="Ebola" post="virus) [[8], [9], [10], [11], [12]]. Originally developed to"/>
  <result pre="virus) [[8], [9], [10], [11], [12]]. Originally developed to treat" exact="Ebola" post="virus infection [8], remdesivir is a prodrug of the"/>
  <result pre="African green monkeys [21]. In a Ces1c-knockout mouse model of" exact="SARS-CoV infection," post="prophylactic and therapeutic remdesivir treatment resulted in lower lung"/>
  <result pre="that randomized 175 patients to be treated with remdesivir for" exact="Ebola" post="[39]. Incidentally, randomization to remdesivir treatment was discontinued in"/>
  <result pre="compassionate use data having been favorable for remdesivir against the" exact="Ebola" post="virus prior to the trial [9]. Interestingly, patients who"/>
  <result pre="Summary, November 2019Available from:https://www.who.int/emergencies/mers-cov/en/(accessed on 9 March 2020) 5MullerM.A.MeyerB.CormanV.M.Al-MasriM.TurkestaniA.RitzD.Presence of" exact="Middle East respiratory syndrome" post="coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological"/>
  <result pre="approachOne Health9202010012432195311 8WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature.5317594201638138526934220 9LoM.K.JordanR.ArveyA.SudhamsuJ.Shrivastava-RanjanP.HotardA.L.GS-5734 and its parent nucleoside"/>
  <result pre="32GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusJ. Biol. Chem.2020 33KirchdoerferR.N.WardA.B.Structure of the SARS-CoV nsp12 polymerase"/>
 </snippets>
</snippetsTree>
